Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BVMF/BIOM3 stock hub

BVMF/BIOM3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/BIOM3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/BIOM3

In the news

Latest news · BVMF/BIOM3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-2.3

P25 n/aP50 n/aP75 n/a

ROIC-1.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/BIOM3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

BRL

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Employees	130
Employees Change	3%
Employees Change Percent	2.36
Enterprise value	BRL 1.1B
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Biotechnology
Isin	BRBIOMACNOR2
Last refreshed	2026-05-10
Market cap	BRL 1B
Price	BRL 7.46
Price currency	BRL
Rev Per Employee	2,071,530.77x
Sector	Healthcare
Sic	2836
Symbol	bvmf/BIOM3
Website	https://www.biomm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.66%
EV Earnings	-162.11x
EV/FCF	-8.06x
EV/Sales	4.03x
FCF yield	-13.17%
P/B ratio	3.26x
P/S ratio	3.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.95%
EBITDA Margin	0.94%
Gross margin	31.55%
Gross Profit	BRL 85M
Gross Profit Growth	375.16%
Gross Profit Growth3 Y	74.48%
Gross Profit Growth5 Y	43.56%
Net Income	BRL -6.7M
Net Income Growth Quarters	4%
Net Income Growth Years	3%
Pretax Margin	-2.58%
Profit Margin	-2.48%
Profit Per Employee	BRL -51,438
ROA	-0.66
Roa5y	-9.88
ROCE	-1.32
ROE	-2.32
Roe5y	-44.25
ROIC	-1.5
Roic5y	-25.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.13%
Cagr15y	8.17%
Cagr1y	-22.55%
Cagr20y	4.41%
Cagr3y	29.05%
Cagr5y	-13.03%
EPS Growth Quarters	6
EPS Growth Years	3
Revenue Growth	88.45x
Revenue Growth Q	316.93x
Revenue Growth Quarters	2x
Revenue Growth Years	3x
Revenue Growth3 Y	36.9x
Revenue Growth5 Y	35.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.54
Assets	BRL 524.2M
Cash	BRL 33.4M
Current Assets	BRL 281.1M
Current Liabilities	BRL 126.2M
Debt	BRL 96.6M
Debt EBITDA	BRL 32.78
Debt Equity	BRL 0.31
Debt FCF	BRL -0.72
Equity	BRL 313.5M
Interest Coverage	-0.48
Liabilities	BRL 210.7M
Long Term Assets	BRL 243.2M
Long Term Liabilities	BRL 84.5M
Net Cash	BRL -63.2M
Net Cash By Market Cap	BRL -6.19
Net Debt EBITDA	BRL 24.94
Net Debt Equity	BRL 0.2
Tangible Book Value	BRL 254.5M
Tangible Book Value Per Share	BRL 1.86
WACC	6.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.23
Inventory Turnover	2.42
Net Working Capital	BRL 167.1M
Quick ratio	1.25
Working Capital	BRL 154.8M
Working Capital Turnover	BRL 1.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	36.07%
1Y total return	-22.54%
200-day SMA	7.53
3Y total return	114.96%
50-day SMA	7.36
50-day SMA vs 200-day SMA	50under200
5Y total return	-50.23%
All Time High	29
All Time High Change	-74.28%
All Time High Date	2020-06-02
All Time Low	0.42
All Time Low Change	1,688.11%
All Time Low Date	2004-07-27
ATR	0.33
Beta	0.44
Beta1y	-0.09
Beta2y	0.06
Ch YTD	3.32
High	7.82
High52	10.66
High52 Date	2025-05-20
High52ch	-30.02%
Low	7.44
Low52	5.75
Low52 Date	2026-01-21
Low52ch	29.74%
Ma50ch	1.43%
Price vs 200-day SMA	-0.97%
RSI	50.07
RSI Monthly	47.11
RSI Weekly	51.18
Sharpe ratio	-0.15x
Sortino ratio	-0.13
Total Return	-6.26%
Tr YTD	3.32
Tr15y	224.77%
Tr1m	-2.36%
Tr1w	-0.53%
Tr3m	24.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL -5.2M
Operating margin	-1.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,560,495%
Net Borrowing	-23,987,000
Shares Insiders	12.66%
Shares Institutions	93.13%
Shares Out	136,841,532
Shares Qo Q	13.97%
Shares Yo Y	6.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL -134.9M
Average Volume	2,153,255x
Bv Per Share	2.29
CAPEX	BRL -22.8M
Ch10y	22.1
Ch15y	191.4
Ch1m	-2.36
Ch1w	-0.53
Ch1y	-24.95
Ch20y	86.5
Ch3m	24.13
Ch3y	102.2
Ch5y	-53.37
Ch6m	12.86
Change	-3.12%
Change From Open	-4.6
Close	7.7
Days Gap	1.56
Depreciation Amortization	7,772,000
Dollar Volume	288,702
Earnings Date	2026-05-15
EBIT	BRL -5.2M
EBITDA	BRL 2.5M
EPS	BRL -0.05
F Score	3
FCF	BRL -134.5M
FCF EV Yield	-12.41x
FCF Per Share	BRL -0.98
Financing CF	33,514,000
Fiscal Year End	December
Founded	2,001
Income Tax	BRL -261,000
Investing CF	22,826,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Ma150	7.54
Ma150ch	-1.1%
Ma20	7.51
Ma20ch	-0.69%
Net CF	-55,316,000
Next Earnings Date	2026-05-15
Open	7.82
Position In Range	5.26
Ppne	163,807,000
Price Date	2026-05-08
Price EBITDA	BRL 403
Ptbv Ratio	4.01
Relative Volume	0.02x
Revenue	269,299,000x
SBC By Revenue	0.15x
Share Based Comp	399,000
Tax By Revenue	-0.1x
Tr20y	136.92%
Tr6m	12.86%
Volume	38,700
Z Score	2.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/BIOM3 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/BIOM3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/BIOM3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+93.1%

Share of float held by funds and institutions

Insider ownership

+12.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+6.3%

Negative means the company is buying back shares.

Technical

BVMF/BIOM3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.1

Neutral momentum band

Price vs 200-day MA

-1.0%

50/200-day relationship not available

Beta (5Y)

0.44

Less volatile than the market

Sharpe ratio

-0.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/BIOM3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/BIOM3 stock rating?

bvmf/BIOM3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/BIOM3 analysis?

The full report lives at /stocks/bvmf/BIOM3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/BIOM3?

The latest report frames bvmf/BIOM3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/BIOM3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.